{
    "pmcid": "11481066",
    "qa_pairs": {
        "What are the main advantages of nanobodies derived from camelid antibodies in targeting the SARS-CoV-2 spike protein receptor binding domain (S-RBD)?": [
            "Their small size, stability, and specific binding ability to antigens.",
            "Their ability to induce a strong immune response and long half-life in the bloodstream.",
            "Their high production yield in mammalian cell cultures and ease of purification.",
            "Their ability to cross the blood-brain barrier and target neurological tissues."
        ],
        "What experimental technique was used to test the binding affinity of selected nanobody mutants in the study?": [
            "Biolayer interferometry (BLI).",
            "Surface plasmon resonance (SPR).",
            "Enzyme-linked immunosorbent assay (ELISA).",
            "Western blotting."
        ],
        "What future refinement did the study suggest to improve the accuracy of predictions in the nanobody design workflow?": [
            "Incorporating entropy calculations in MD simulations for more accurate \u0394\u0394G predictions.",
            "Using larger datasets for training machine learning models.",
            "Increasing the number of experimental validation steps.",
            "Developing new nanobody scaffolds with enhanced solubility."
        ],
        "What was identified as a challenge in the nanobody design workflow according to the study?": [
            "The lack of stability prediction and limitations of ML methods in predicting binding affinity.",
            "The high cost and time consumption of molecular dynamics simulations.",
            "The inability to produce nanobodies in bacterial expression systems.",
            "The difficulty in obtaining high-resolution crystal structures of nanobody-antigen complexes."
        ],
        "Which machine learning methods were used in the study to predict the effects of mutations on nanobody binding affinity?": [
            "mCSM-PPI2, MutaBind2, and SAAMBE-3D.",
            "DeepBind, AlphaFold, and Rosetta.",
            "TensorFlow, PyTorch, and Keras.",
            "BLAST, Clustal Omega, and MUSCLE."
        ]
    }
}